Sign Up

Burden of Disease Epidemiology, Equity & Cost-Effectiveness Programme (BODE³)

Research Study

originally posted by WM Admin on 17 October 2012 and updated 9 April 2015

Description

The Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme (BODE³) has an aim to build capacity and academic rigour in New Zealand in the estimation of disease burden, cost-effectiveness and equity impacts of proposed interventions, and undertake a range of such assessments.

It is a Health Research Council (HRC) funded programme, for 2010 to 2015. Major collaborative partners include the University of Queensland and the Ministry of Health.

Start Date

Nov 1, 2010

End Date

Dec 1, 2015

Status

In Progress

Dissemination

The programme webpage is at: http://www.otago.ac.nz/wellington/research/bode3/index.html

Funders

Health Research Council of New Zealand

Research Abstracts

Cancer excess mortality rates over 2006-2026 for ABC-CBA

Technical report: Estimating the modelling parameters around dietary counselling for preventing cardiovascular disease in New Zealand

Patterns of cancer care costs in a country with detailed individual data

Projecting future smoking prevalence to 2025 and beyond in New Zealand using smoking prevalence data from the 2013 Census

Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: A cost-utility analysis in a country with an existing school-girl program

Understanding price elasticities to inform public health research and intervention studies: Key issues

Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure

Modelling the implications of regular increases in tobacco taxation in the tobacco endgame

Theoretical impacts of a range of major tobacco retail outlet reduction interventions: Modelling results in a country with a smoke-free nation goal

Ways and means: A report on methodology from the New Zealand Burden of Disease, Injury and Risk Study, 2006 - 2016

Why equal treatment is not always equitable: The impact of existing ethnic health inequalities in cost-effectiveness modeling

The burden of cancer in New Zealand: A comparison of incidence and DALY metrics and its relevance for ethnic disparities

Estimating the cost of new public health legislation

What will it take to get to under 5% smoking prevalence by 2025? Modelling in a country with a smokefree goal

Health loss in New Zealand: A report from the New Zealand Burden of Diseases, Injuries and Risk Factors Study, 2006–2013

Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand

Injury-related health loss A report from the New Zealand Burden of Diseases, Injuries and Risk Factors Study 2006–2016

Protocol for direct costing of health sector interventions for economic modelling (including event pathways)

Background report for BODE3 modelling on estimating the impact of the Tick Programme in New Zealand (a heart health food endorsement programme)

Approaches to prioritisation and health technology assessment in New Zealand